Corrigenda and Addenda
doi:10.2196/50411
In “The Efficacy, Safety, and Efficiency of the Off-Label Use of Bevacizumab in Patients Diagnosed With Age-Related Macular Degeneration: Protocol for a Systematic Review and Meta-Analysis” (JMIR Res Protoc 2023;12:e38658) the authors noted a missing Acknowledgments section. The Acknowledgments section has now been added to the published paper as follows:
H&TRC authors gratefully acknowledge the FCT/MCTES national support through the UIDB/05608/2020 and UIDP/05608/2020.
The correction will appear in the online version of the paper on the JMIR Publications website on July 4, 2023, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.
This is a non–peer-reviewed article. submitted 29.06.23; accepted 30.06.23; published 04.07.23.
Copyright©João Estarreja, Priscila Mendes, Carina Silva, Pedro Camacho, Vanessa Mateus. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 04.07.2023.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.